Clinical Trial

the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration

Name: the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration — clinical trial record (NCT07375901)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BABAMD

Completed

View on ClinicalTrials.gov →

Summary

To evaluate the status of the blood-aqueous barrier by objectively measuring protein concentration in the aqueous humor using laser flare photometry (LFP) in patients with exudative age-related macular degeneration (AMD) undergoing anti-angiogenic therapy.

Trial Details

NCT Number	NCT07375901
Lead Sponsor	The Filatov Institute of Eye Diseases and Tissue Therapy
Conditions	AMD
Enrollment	30 participants
Start Date	2021-03-25
Primary Completion	2023-04-15 (estimated)
Study Completion	2024-04-10 (estimated)
Updated on ClinicalTrials.gov	2026-01-29